SENSEX NIFTY
Kokuyo Camlin > Company History > Diversified > Company History of Kokuyo Camlin - BSE: 523207, NSE: KOKUYOCMLN
YOU ARE HERE > MONEYCONTROL > MARKETS > DIVERSIFIED > COMPANY BACKGROUND - Kokuyo Camlin
Kokuyo Camlin
BSE: 523207|NSE: KOKUYOCMLN|ISIN: INE760A01029|SECTOR: Diversified
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 22, 16:20
62.95
2.65 (4.39%)
VOLUME 276,845
LIVE
NSE
Aug 22, 16:20
63.50
3.3 (5.48%)
VOLUME 628,915
Company History - Kokuyo Camlin
YEAR                       EVENTS
 1946 - The Company was incorporated on 24th December, as a private 
        limited company with the main object of taking over the
 running
        business of M/s. Dandekar & Co., which was founded by late 
        G.P. Dandekar and D.P. Dandekar in 1931 at Girgaum, Mumbai. 
 The
        Company manufacture stationary products, art materials and
        pharmaceuticals.  The Company was converted into a public
 limited
        company on 24th March, 1988 and the name was changed to
 Camlin
        Ltd.
 
      - The initial product range of M/s. Dandekar & Co., comprised
 of
        ink tablets, fountainpen ink, office adhesives, sealing wax,
        school chalks, brilliantine, pain balm, etc. which took part
 in
        business activities in 1939 and was shifted to Mahim, Mumbai.
 
 1964 - The Company embarked on the first diversification of products
 
        by producing for the first time in India, the complete range
 of
        artist colours and materials such as water colours, poster 
        colours, oil colours, fabric colours, geometry boxes, drawing
 
        inks, painting brushes and canvases.  Many products were also
        added subsequently.
 
 1974 - The production of wood cased pencils was taken up in the fully
 
        integrated plant in the industrially backward area of
 Tarapur,
        Maharashtra.
 
 1978 - In December 1947, 600 shares issued without payment in cash
 to
        vendores as part consideration for taking over their business.
  
        Till date, 32,250 shares were issued as bonus shares by
        capitalisation of reserves (2,250 shares in Dec. 1966 in
 prop.
        1:2; 10,000 shares in March 1975 in prop. 1:1 and 20,000
 shares   
        in April in prop. 1:1.
 
 1981 - As on 31st December, the company was holding 6,00,000 fully
 paid
        up equity shares of M.$ 1 each.  
 
 1982 - A joint venture company Camlin N.S. Sdn. Bhd set up in 
        Malaysia was closed down with effect from 28th February,  
        following a directive from the Malaysian Government in line
 with
        its decision to order closure of operations of all the joint
        venture companies which were incurring losses over the past
        many years.
  
      - After obtaining necessary approvals from the Ministry of
 Commerce
        Government of India, the Company divested its entire
 shareholding
        amounting to M $ 6,80,000.
 
 1984 - The Company took a major step forward by diversifying its 
        manufacturing and marketing activity into the field of 
        pharmaceuticals, ie., bulk drugs and formulations at Tarapur.
 
      - The Company acquired a licence to manufacture 42.100 tonnes
 per
        annum of bulk drugs such as Diloxanide Fuorate, Mebendzole, 
        Diazepam and Ibuprofen.  A plant at Tarapur was set up with 
        an installed capacity of 15,400 tonnes per annum.
 
 1986 - Workers of the pencil factory at Tarapur went on strike with
        effect from 10th March.  The operations were restarted only
 on
        19th October after signing an agreement with the Labour Union
        valid upto 31st March, 1989.
 
 1987 - The Company decided to set up a plant at Tarapur for the 
        manufacture of Hi-Polymer Lead.  A technical know-how
 agreement
        valid for a period of 5 years was concluded in
 November/December
        with Pilot Pen Co. Ltd., of Japan.
 
      - In April, 3,200 No. of equity shares of Rs.100 each issued at
 par
        Equity shares then sub-divided.  4,32,000 bonus equity shares
 of
        Rs.10 each issued in prop. 1:1 in October 1987.
 
 1988 - The Company's products are marketed under the brand names of 
        Camel and Camlin.  Its Analytical Laboratory at Andheri is
        recognised as a public testing house by State Food & Drug 
        Administration of Maharashtra and the R & D laboratory is 
        aproved by the Department of Scientific and Industrial
 Research,
        Government of India.
 
      - During June, some of the then existing shareholders of the 
        Company offered for sale 3,00,000 equity shares of Rs.10 each
 at 
        a premium of Rs.20 per share to enable the Company to list its
 
        shares on the recognised Stock Exchanges.  Out of the total 
        shares offered for sale, 15,000 shares were reserved and
 allotted
        on a preferential basis to the employees (including Indian
        working directors) of the Company.  The balance 2,85,000
 shares
        were offered for sale to the public (all were taken up).
 
      - During June, the company offered 1,00,000-14% secured
 redeemable
        convertible debentures of Rs.240 each for cash at par.  Out of
 
        which, 5,000 debentures were reserved for preferential
 allotment
        to employees/Indian working directors/workers of the Company
        (only 2,050 debentures taken up) and 11,000 debentures were 
        reserved for allotment of UTI on firm basis.  The remaining 
        84,000 debentures, along with the unsubscribed 2,950
 debentures
        of employees quota were offered for public subscription.  All
 the
        debentures were taken up.  150 debentures were forfeited
 during
        1989-90.
 
      - Each debenture consists of a convertible portion of Rs.140 and
 a
        non-convertible portion of Rs.100.  At the end of six months
 from
        the date of allotment of debentures, Rs.140 of each debenture
        was automatically and compulsorily converted into 5 equity
 shares
        of Rs.10 each at a premium of Rs.18 per share.  The 
        non-convertible portion of Rs.100 of each debenture shall be
        redeemed at par in three equal instalments at the end of 7th,
 8th
        and 9th year from the date of their allotment by drawing
 three
        equal lots.
 
      - 96,000 shares issued at par in March 1988.  4,80,000 bonus
 shares
        issued in June 1988 in prop. 1:2 to shareholders prior to the
        offer for sale to the public.  4,97,550 shares allotted
 (prem.
        Rs.18 per share) in conversion of debentures.
   
 1989 - 1,700 shares were allotted (prem. Rs.18 per share) in
 conversion
        of debs.
 
 1990 - 750 shares issued in conversion of debs. (prem. Rs.18 per
 share).
 
 1991 - As at 31st March, 1991, the Company revalued its land and 
        buildings and the net surplus of Rs.330.26 lakhs arising out
 of
        it was credited to the revaluation reserve.
 
 1994 - The Company entered into a marketing alliance with Colart Fine
 
        Art & Graphics Ltd. U.K.
 
      - The Company embarked upon a project for expanding
 manufacturing 
        capacities of existing bulk drugs/chemical plant at Tarapur.
 
      - The Company undertook to set up a facility for manufacture of
 
        industrial grade synthetic adhesives at Taloja near Mumbai.  
 
      - The Company issued Warrants to promoter group on preferential
        allotment basis.  Of the 4,60,000 warrants, 3,32,000 warrants
        were converted into equity shares.
 
      - 3,32,100 equity shares allotted in conversion of warrants.
 
 1995 - A major fire broke at Tarapur factory due to suspected
 electrical
        short circuit which led to destruction of godown, raw
 materials
        etc.
 
      - The Company initiated measures such as introduction of new 
        products, change in product-mix, reduction in overheads and
        thrust on higher value addition.
  
      - 71,900 No. of Equity shares allotted in conversion of
 warrants.
 
 1996 - 56,000 No. of Equity shares allotted in conversion of
 warrants.
 
 1997 - The Joint Venture Agreement with M/s. A. W. Faber-Castell Gmbh
 &
        Co. Germany was terminated by both parties with effect from
 30th
        November.
 
      - The company redeemed the last instalment of 33,340-14%
 Secured
        Redeemable Non-Convertible Debentures of Rs 100/- each issued
        in the year 1988.
 
 2002
 
 -Camlin Ltd has informed that Mr S D Dandekar, Executive Chairman of
 the Company, will be retiring from the Chairmanship of the Company.
 Mr D D Dandekar, Managing Director of the Company will be
 redesignated as Chairman and Managing Director w e f June 01, 2002.
 
 
 2004
 
 -Camlin Pharma, a division of Camlin Ltd, launched its mosquito
 repellent body spray, Repelmos, in the southern states
 
 -Delist from The Delhi Stock Exchange Association Ltd (DSE) with
 effect from December 11, 2004.
 
 
 2005
 
 -Camlin - JV with ColArt Fine Art & Graphics, U.K
 
 2008
 
 - The Company has splits its face value from Rs10/- to Rs1/-.
 
 
 2011
 
 -The Company have appointed M/s. Bigshare Services Private Limited
 having office at E/2,, Ansa Industrial Estate, Saki-Vihar Road,
 Sakinaka, Andheri (E), Mumbai - 400072 as Company's Registrar and
 Transfer Agents for the Company.
 
 2012
 
 -Company has changed its name from Camlin Ltd. to Kokuyo Camlin Ltd. 
                                                        
                                                                
Source : Dion Global Solutions Limited
Quick Links for Kokuyo Camlin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.